T3 - Lupus Eritematoso Sistémico e Síndroma do Anticorpo Antifosfolipídico Flashcards
Definição de LES?
Multisystem chronic autoimmune disorder
Broad-spectrum of clinical presentations
A waxing and waning course
Variable prognosis
Epidemiologia de LES?
Women are affected up to nine times more frequently than men
Peak age of onset among women is between the late teens and early 40s
Etiologia de LES?
Genetic factors
Environmental factors
Hormonal factors
Patogénese de LES?
Irreversible breakdown of immunological tolerance manifested by aberrant immune responses against endogenous nuclear and other self-antigens and deposition of immune complexes.
Critérios de Classificação de LES?
ACR e SLICC
No mínimo 4 critérios , 1 imunológico e outro clínico
Exemplos de critérios clínicos de LES?
Lupus cutaneo cronico ou agudo Ulveras nasais ou orais Alopecia nao cicatrizante Artrite Serosite
Exemplos de critérios imunológicos de LES?
ANA
Anti-dsDNA
Anti-Sm
Low complement (C3, C4 e CH50)
Achados clínicos constitucionais de LES?
Febre
Perda de peso
Fadiga
Anorexia
Manifestações mucocutâneas específicas de LES?
Rash malar, Rash difuso, lesões bulhosas
Manifestações mucocutâneas não específicas de LES?
Photosensitivity Alopecia (non-scarring) Vasculitis Periungal erythema Raynaud phenomenon Oral/Nasal ulcers
Manifestações musculoesqueléticas de LES?
Non-erosive, non-deforming arthralgias/arthritis primarily affecting the small joints of the hands, wrists and knees
Jaccoud arthropathy
Erosive arthropathy overlapping rheumatoid arthritis features (ruphus)
Diferenças entre artrite de LES e AR?
Menos inflamatórias, não deformantes e não erosivas.
Outras manifestações musculoesqueléticas de LES?
Tenosynovitis
Myositis
Avascular bone necrosis
Manifestações renais de LES?
Hypertension – new onset Nephrotic syndrome Renal failure Proteinuria Haematuria
Confirmação de Nefrite Lúpica?
Renal biopsy
Manifestações Neuropsiquiátricas de LES?
Very heterogeneous
Manifestações Cardiovasculares de LES?
Pericarditis Pericardial Infusion Myocarditis Cardiovascular Disease (accelerated, premature atherosclerosis) Endocarditis
Manifestações Pleuropulmonares de LES?
Pleuritic chest pain (45-60%) Pleural effusion (50%) Acute pneumonitis (1-4%) Interstitial lung disease (3-13%) Diffuse alveolar hemorrhage Shrinking-lung syndrome Pulmonary hypertension
Manifestações Hematológicas de LES?
Lymphadenopathy (40%) Splenomegaly (10-45%) Anaemia - normocrómica normocítica Leucopenia (30-40%) Trombocitopenia
Manifestações Gastrointestinais de LES?
Mesenteric vasculitis
Pancreatitis
Hepatitis
Manifestações Oftálmicas de LES?
Vasculitis of retinal artery
Corneal and conjunctiva involvement
Diagnostic workup in LES?
Full blood count Urea, creatinine, ionogram Liver function tests Inflammatory markers (CRP, ESR) CK, DHL Coagulation tests Urinalysis
Antibodies in Diagnostic workup of LES?
Antinuclear antibodies Anti-dsDNA Complement (C1q, C3, C4) Lupus anticoagulant Anticardiolipin Direct Coombs test Anti-ENA (Anti-SSa, Anti-SSb, Anti-Sm, Anti-RNP) Anti-ribosomal Anti-Histone
Gravidez e LES?
Pregnancy may increase lupus activity but flares are usually mild
Pregnancy outcome is optimal when in clinical remission for 6-12 months, renal function is normal and appropriate drugs
Patients with lupus nephritis and antiphospholipid antibodies: ↑ pre-eclampsia
Síndrome Antifosfolipídico?
Vascular thrombosis
Pregnancy morbidity
Lupus anticoagulant positivity
Anticardiolipin antibody
Complicações da gravidez em LES?
Miscarriage
Stillbirth
Premature delivery
Intrauterine growth restriction
Lúpus neo-natal?
Anticorpos Anti-SSa e SSb ultrapassam a placenta.
Possível bloqueio completo auriculo-ventricular.
Lupus Juvenil?
15-20% of SLE cases
More aggressive disease in children than in adults
↑ renal and neurologic involvement
↓ pleuritis, sicca symptoms
SLE in the elderly?
10-20% of SLE cases
Delayed diagnosis and less common occurrence of severe manifestations
↑ serositis, pulmonary involvement, sicca symptoms, and musculoskeletal manifestations
↓ malar rash, photosensitivity, purpura, alopecia, Raynaud’s phenomenon, renal and central nervous system (CNS) involvement
Drug-Induced Lupus?
Patient with no previous diagnosis or history of SLE
Develops ANA positivity and at least one clinical feature of SLE after drug exposure
Typical clinical features
Anti-histone antibodies > 95%
Hypocomplementaemia and Anti-dsDNA antibodies rare
Tratamento de LES?
General measures (Sun avoidance)
Immunization
Bone health
Tratamento Farmacológico de LES?
Corticosteroids Hydroxychloroquine (Atenção MACULOPATIA) Cyclophosphamide (severe disease) Azathioprine Mycophenolate mofetil Methotrexate
Terapias biológicas de LES?
Rituximab
Belilmumab
How to monitor LES?
Disease Activity Indices
Chronicity and Damage Index